✦ LIBER ✦

Use of biological disease-modifying anti-rheumatic drugs in patients with concurrent rheumatic disease and hepatitis B

✍ Scribed by L. K. King; A. Lee; A. Anandacoomarasamy

Book ID: 115183326
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 156 KB
Volume: 42
Category: Article
ISSN: 1444-0903
DOI: 10.1111/j.1445-5994.2011.02569.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of conventional disease-modifyin

The use of conventional disease-modifying anti-rheumatic drugs in established RA

✍ M.S. Jurgens; J.W.G. Jacobs; J.W.J. Bijlsma 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 361 KB

PMS74 Use of Disease-Modifying Anti-Rheu

PMS74 Use of Disease-Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis in Quebec, Canada

✍ J.P. Roussy; L. Bessette; S. Bernatsky; E. Rahme; J. Légaré; J. Lachaine 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Optimizing outcomes in rheumatoid arthri

Optimizing outcomes in rheumatoid arthritis patients with inadequate responses to disease-modifying anti-rheumatic drugs

✍ Pavelka, K.; Kavanaugh, A. F.; Rubbert-Roth, A.; Ferraccioli, G. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 413 KB

Therapy-related lymphomas in patients wi

✍ Wing-Yan Au; Edmond S.K. Ma; Carolyn Choy; Lap-Ping Chung; Tsz-Kin Fung; Raymond 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 2 views

Comparative cancer risk associated with

Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugs

✍ Solomon, Daniel H.; Kremer, Joel M.; Fisher, Mark; Curtis, Jeffrey R.; Furer, Vi 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 355 KB

Radiographic outcome in Hispanic early r

Radiographic outcome in Hispanic early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs

✍ Irazú Contreras-Yáñez; Marina Rull-Gabayet; Jorge Vázquez-LaMadrid; Virginia Pas 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 383 KB